Apollo Hospitals to Buy IFC’s 30.6% Stake in AHLL for ₹1,254 Cr, Plans New Oncology Centre
Apollo Hospitals will acquire IFC’s 30.6% stake in Apollo Health and Lifestyle Ltd for ₹1,254 crore, making AHLL a full subsidiary. The group also announced a ₹573 crore oncology facility in Gurugram.
New Delhi: Apollo Hospitals Enterprise Ltd (AHEL) on Friday announced that it will purchase the 30.6% equity stake held by International Finance Corporation (IFC) and IFC EAF in its subsidiary Apollo Health and Lifestyle Ltd (AHLL) for ₹1,254 crore. Following this deal, AHLL will become a wholly owned subsidiary, strengthening Apollo’s integrated healthcare model.
The company said the move will help consolidate operations, streamline diagnostics, and improve efficiency across verticals such as primary care, women’s health, ambulatory services, dialysis, and dental care. Managing Director Suneeta Reddy noted that complete ownership would enable sharper capital allocation and stronger growth in high-potential segments.
Joint Managing Director Sangita Reddy added that while IFC had been a valuable partner in AHLL’s growth journey, bringing the business fully under Apollo would accelerate innovation and allow more personalised, accessible, and future-ready care.
Alongside the acquisition, the board also approved setting up a ₹573 crore comprehensive oncology centre in Gurugram, expected to serve an additional 350 patients annually by FY 2029
With this buyout, Apollo gains greater control over its healthcare ecosystem, which is crucial as competition intensifies in diagnostics and specialty care. The investment in oncology also highlights the growing demand for advanced cancer treatment facilities in North India.